M. Feder

发表

Phylogenomic analysis of the GIY-YIG nuclease superfamily

Marcin Feder, Janusz M Bujnicki, Stanislaw Dunin-Horkawicz, 2006, BMC Genomics.

Errors in the D. radiodurans large ribosomal subunit structure detected by protein fold‐recognition and structure validation tools

Leszek Rychlewski, Marcin Feder, Janusz M Bujnicki, 2002, FEBS letters.

Structural model for the multisubunit Type IC restriction–modification DNA methyltransferase M.EcoR124I in complex with DNA

J. Bujnicki, K. Firman, M. Weiserová, 2006, Nucleic acids research.

Mutational analysis defines the roles of conserved amino acid residues in the predicted catalytic pocket of the rRNA:m6A methyltransferase ErmC'.

S. Pongor, J. Bujnicki, M. Feder, 2003, Journal of molecular biology.

Characterization of prmt7α and β isozymes from Chinese hamster cells sensitive and resistant to topoisomerase II inhibitors

J. Bujnicki, A. Jacquemin-Sablon, B. Vincent, 2006 .

Qualitative structure residue relationship analysis in the determination of the maximum residue limit of veterinary drugs.

W. Piotrowski, T. Grabowski, M. Feder, 2012, Chemosphere.

Sequence–structure–function relationships of a tRNA (m7G46) methyltransferase studied by homology modeling and site‐directed mutagenesis

J. Bujnicki, F. Van Vliet, C. Tricot, 2005, Proteins.

Correlations between the selected parameters of the chemical structure of drugs and between-subject variability in area under the curve

T. Grabowski, M. Feder, J. Jaroszewski, 2013, Medicinal Chemistry Research.

Virtual Screening and Experimental Verification to Identify Potential Inhibitors of the ErmC Methyltransferase Responsible for Bacterial Resistance against Macrolide Antibiotics

Marcin Feder, Janusz M Bujnicki, Elzbieta Purta, 2008, ChemMedChem.

Sequence-structure-function studies of tRNA:m5C methyltransferase Trm4p and its relationship to DNA:m5C and RNA:m5U methyltransferases.

Marcin Feder, Janusz M. Bujnicki, Kent L. Redman, 2004, Nucleic acids research.

MODOMICS: a database of RNA modification pathways

Marcin Feder, Janusz M. Bujnicki, Michal J. Gajda, 2005, Nucleic Acids Res..

Computational Methods for Protein Structure Prediction and Fold Recognition

Marcin Feder, Janusz M. Bujnicki, Iwona A. Cymerman, 2008 .

The PD-(D/E)XK superfamily revisited: identification of new members among proteins involved in DNA metabolism and functional predictions for domains of (hitherto) unknown function

Marcin Feder, Jan Kosinski, Janusz M. Bujnicki, 2005, BMC Bioinformatics.

FRankenstein becomes a cyborg: The automatic recombination and realignment of fold recognition models in CASP6

Marcin Feder, Michal J Gajda, Jan Kosinski, 2005, Proteins.

A “FRankenstein's monster” approach to comparative modeling: Merging the finest fragments of Fold‐Recognition models and iterative model refinement aided by 3D structure evaluation

Marcin Feder, Jan Kosinski, Michal A Kurowski, 2003, Proteins.

Molecular phylogenetics of the RrmJ/fibrillarin superfamily of ribose 2'-O-methyltransferases.

Jakub Pas, Marcin Feder, Janusz M Bujnicki, 2003, Gene.

Identification of a new family of putative PD-(D/E)XK nucleases with unusual phylogenomic distribution and a new type of the active site

Marcin Feder, Janusz M Bujnicki, J. Bujnicki, 2005, BMC Genomics.

Type II restriction endonuclease R.Eco29kI is a member of the GIY-YIG nuclease superfamily

Marcin Feder, Janusz M Bujnicki, Dominik Gront, 2007, BMC Structural Biology.

Ligand-Optimized Homology Models of D1 and D2 Dopamine Receptors: Application for Virtual Screening

Marcin Feder, Marcin Kołaczkowski, Adam Bucki, 2013, J. Chem. Inf. Model..

mRNA:guanine-N7 cap methyltransferases: identification of novel members of the family, evolutionary analysis, homology modeling, and analysis of sequence-structure-function relationships

Leszek Rychlewski, Marcin Feder, Janusz M. Bujnicki, 2001, BMC Bioinformatics.

Correlation Between In Silico Physicochemical Characteristics of Drugs and Their Mean Residence Time in Human and Dog

S. Gad, T. Grabowski, M. Feder, 2012, International journal of toxicology.

Structure Prediction and Phylogenetic Analysis of a Functionally Diverse Family of Proteins Homologous to the MT-A70 Subunit of the Human mRNA:m6A Methyltransferase

Marcin Feder, Janusz M. Bujnicki, Monika Radlinska, 2002, Journal of Molecular Evolution.

Complete Cap 4 Formation Is Not Required for Viability in Trypanosoma brucei

J. Bujnicki, D. Campbell, J. Zamudio, 2006, Eukaryotic Cell.

Relationship between Tetracyclines’ Structure and Minimal Inhibitory Concentration of Streptococcus spp.

T. Grabowski, M. Feder, M. Marczak, 2014, Drug Research.

Alanine-scanning mutagenesis of the predicted rRNA-binding domain of ErmC' redefines the substrate-binding site and suggests a model for protein-RNA interactions.

S. Pongor, J. Bujnicki, M. Feder, 2003, Nucleic acids research.

Characterization of prmt7alpha and beta isozymes from Chinese hamster cells sensitive and resistant to topoisomerase II inhibitors.

J. Bujnicki, A. Jacquemin-Sablon, L. Gros, 2006, Biochimica et biophysica acta.

Characterization of the cofactor-binding site in the SPOUT-fold methyltransferases by computational docking of S-adenosylmethionine to three crystal structures

Marcin Feder, Janusz M. Bujnicki, Michal A. Kurowski, 2003, BMC Bioinformatics.

Novel inhibitors of the rRNA ErmC' methyltransferase to block resistance to macrolides, lincosamides, streptogramine B antibiotics.

J. Bujnicki, I. Tuszynska, F. Stefaniak, 2018, European journal of medicinal chemistry.